Neurobiology of Aging
Volume 29, Issue 8 , Pages 1190-1198 , August 2008

Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease

  • Davis Ryman

      Affiliations

    • Lerner Research Institute, Cleveland Clinic Foundation, Department of Neurosciences, NC3-164, 9500 Euclid Avenue, Cleveland, OH 44195 USA
    • Case Western Reserve University School of Medicine, Department of Genetics, 10900 Euclid Avenue, Cleveland, OH 44106-4955, USA
    • ,
  • Yuan Gao

      Affiliations

    • Case Western Reserve University School of Medicine, Department of Genetics, 10900 Euclid Avenue, Cleveland, OH 44106-4955, USA
    • ,
  • Bruce T. Lamb

      Affiliations

    • Lerner Research Institute, Cleveland Clinic Foundation, Department of Neurosciences, NC3-164, 9500 Euclid Avenue, Cleveland, OH 44195 USA
    • Case Western Reserve University School of Medicine, Department of Genetics, 10900 Euclid Avenue, Cleveland, OH 44106-4955, USA
    • Case Western Reserve University School of Medicine, Department of Neuroscience, 10900 Euclid Avenue, Cleveland, OH 44106-4955, USA
    • Corresponding Author InformationCorresponding author at: Lerner Research Institute, Cleveland Clinic Foundation, Department of Neurosciences, NC3-164, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Tel.: +1 216 444 3592; fax: +1 216 444 7927.

Received 25 October 2006 ,Revised 23 January 2007 ,Accepted 10 February 2007.

References 

  1. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 2003;12:23–32
  2. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol. Immunol. 2007;44:999–1010
  3. Brich J, Shie FS, Howell BW, Li R, Tus K, Wakeland EK, et al. Genetic modulation of tau phosphorylation in the mouse. J. Neurosci. 2003;23:187–192
  4. Cam JA, Zerbinatti CV, Knisely JM, Hecimovic S, Li Y, Bu G. The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production. J. Biol. Chem. 2004;279:29639–29646
  5. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963–971
  6. Fan R, Tenner AJ. Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures. Exp. Neurol. 2004;185:241–253
  7. Gatz M, Fratiglioni L, Johansson B, Berg S, Mortimer JA, Reynolds CA, et al. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol. Aging. 2005;26:439–447
  8. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry. 2006;63:168–174
  9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349:704–706
  10. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  11. Hillebrandt S, Wasmuth HE, Weiskirchen R, Hellerbrand C, Keppeler H, Werth A, et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 2005;37:835–843
  12. Kamboh MI. Molecular genetics of late-onset Alzheimer's disease. Ann. Hum. Genet. 2004;68:381–404
  13. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, et al. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 1999;8:237–245
  14. Krezowski J, Knudson D, Ebeling C, Pitstick R, Giri RK, Schenk D, et al. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression. Hum. Mol. Genet. 2004;13:1989–1997
  15. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, et al. Introduction and expression of the 400kb amyloid precursor protein gene in transgenic mice. Nat. Genet. 1993;5:22–30
  16. Lee JH, Mayeux R, Mayo D, Mo J, Santana V, Williamson J, et al. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Mol. Psychiatry. 2004;9:1042–1051
  17. Lehman EJ, Kulnane LS, Gao Y, Petriello MC, Pimpis KM, Younkin L, et al. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Hum. Mol. Genet. 2003;12:2949–2956
  18. Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S, et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum. Mol. Genet. 2006;15:2560–2568
  19. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet. 2002;70:985–993
  20. Lynch M, Walsh B. Genetics and Analysis of Quantitative Traits. Sunderland, Massachusettes: Sinauer Associates, Inc.; 1998;
  21. Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm. Genome. 1999;10:327–334
  22. Marschang P, Brich J, Weeber EJ, Sweatt JD, Shelton JM, Richardson JA, et al. Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1. Mol. Cell. Biol. 2004;24:3782–3793
  23. Martin MV, Dong H, Vallera D, Lee D, Lu L, Williams RW, et al. Independent quantitative trait loci influence ventral and dorsal hippocampal volume in recombinant inbred strains of mice. Genes Brain Behav. 2006;5:614–623
  24. McGeer PL, Rogers J, McGeer EG. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers. Dis. 2006;9:271–276
  25. Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. The X11 proteins. Abeta production and Alzheimer's disease. Trends Neurosci. 2006;29:280–285
  26. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, et al. Full genome screen for Alzheimer disease: stage II analysis. Am. J. Med. Genet. 2002;114:235–244
  27. Peng T, Hao L, Madri JA, Su X, Elias JA, Stahl GL, et al. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J. Clin. Invest. 2005;115:1590–1600
  28. Pericak-Vance MA, Bass ML, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, et al. Complete genomic screen in late-onset familial Alzheimer's disease. Neurobiol. Aging. 1998;19:S39–S42
  29. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, et al. Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerontol. 2000;35:1343–1352
  30. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat. Rev. Genet. 2007;8:58–69
  31. Pickering MC, Warren J, Rose KL, Carlucci F, Wang Y, Walport MJ, et al. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2006;103:9649–9654
  32. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775–778
  33. Sebastiani G, Krzywkowski P, Dudal S, Yu M, Paquette J, Malo D, et al. Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice. Hum. Mol. Genet. 2006;15:2313–2323
  34. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754–760
  35. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Newman TT, Breitner JC. APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives. Neurology. 2000;54:593–598
  36. Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, et al. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 2000;66:196–204
  37. Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J. Biol. Chem. 1990;265:2435–2440
  38. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006;12:1005–1015
  39. Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 1999;154:927–936
  40. Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB. A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics. 1998;50:121–128

PII: S0197-4580(07)00059-0

doi: 10.1016/j.neurobiolaging.2007.02.017

Neurobiology of Aging
Volume 29, Issue 8 , Pages 1190-1198 , August 2008

Article Tools

* Image Usage & Resolution